Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
Observational
Observational Model: Cohort, Time Perspective: Prospective
Prescription conditions and use of Low Molecular Weight Heparin in the French usual practice for the treatment of symptomatic Venous Thromboembolism in patients with cancer at up to 6 months
up to 6 months
No
Dominique Farge Bancel, Pr
Principal Investigator
Groupe Francophone Thrombose et Cancer
France: Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé
Tropique
NCT01803022
November 2012
June 2014
Name | Location |
---|